Results 51 to 60 of about 9,872 (176)

Early calcific degeneration of the St. Jude Medical Epic aortic bioprosthesis

Clinical Case Reports, 2020
This report highlights the need for close surveillance of bioprosthetic valves. Unaccountable degeneration of bioprosthetic valves can develop early after implantation and usually requires replacing the failed valve with a mechanical prosthesis.
Mohammad Bashar Izzat, Nada Sabbagh, Hazem Aljasem   +2 more
doaj   +1 more source

Reduced Complement and Granulocyte Activation by α‐Gal Knockout Porcine Pericardium for Bioprosthetic Heart Valves: A Pilot Hemocompatibility Study

Journal of Biomedical Materials Research Part A, Volume 114, Issue 7, July 2026.
Genetically modified, α‐Gal‐depleted porcine pericardium and wild type tissues are investigated for hemocompatibility and material properties such as mechanobiology and ECM profile to carve out the suitability of the gene‐modified tissue as material for biological heart valve prostheses. ABSTRACT Xenogeneic pericardium is the main source for biological
Claudia Dittfeld, Elisabeth Kemter, Barbara Kessler, Eckhard Wolf, Anett Jannasch, Claudia Sperling, Sems‐Malte Tugtekin, Manfred F. Maitz   +7 more
wiley   +1 more source

Around and Through: Successful Mitral Paravalvular Leakage Closure Using Both Anterograde and Retrograde Approaches

Catheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2179-2182, June 1, 2026.
ABSTRACT Paravalvular leak (PVL) is a recognized complication after surgical mitral valve replacement and may cause heart failure, pulmonary hypertension, or hemolysis when moderate or severe. Although redo surgery is the definitive treatment, it carries substantial risk in elderly patients or those with multiple prior cardiac surgeries.
Marco Garaventa, Luca Nai Fovino, Tommaso Fabris, Giuseppe Tarantini   +3 more
wiley   +1 more source

VITTA TRIAL – safety and performance at 3-year follow-up after implantation of the VIVERE® aortic bioprosthesis

Frontiers in Cardiovascular Medicine
IntroductionThe durability of aortic bioprostheses remains limited by progressive tissue calcification, the main mechanism underlying structural valve deterioration.
Luiz Carlos Bettiati Junior, Davi Jean Buoro Cassano, Caio Eduardo Gullo, João Carlos Ferreira Leal   +3 more
doaj   +1 more source

Early Outcomes of Real‐World Aortic Valve Replacement With RESILIA Tissue in the Chinese Population

Clinical Cardiology, Volume 49, Issue 6, June 2026.
In this real‐world study of 250 Chinese patients scheduled for elective aortic valve replacement, the INSPIRIS RESILIA aortic valve demonstrated favorable 1‐year safety, with a 98.0% rate of freedom from all‐cause mortality and no observed structural valve deterioration, alongside stable hemodynamic performance.
Haitao Xu, Yang Yan, Xin Chen, Jiangang Wang, Hansong Sun   +4 more
wiley   +1 more source

Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk

Catheterization and Cardiovascular Interventions, Volume 107, Issue 6, Page 2124-2134, May 1, 2026.
ABSTRACT Background Development of conduction abnormalities requiring pacing after transcatheter aortic valve replacement (TAVR) is relatively common. The effects of post‐TAVR permanent pacemaker (PPM) implantation on mortality, ischemic stroke, and cardiovascular outcomes remain incompletely characterized.
Omar Saleh, Nicholas J. Valle, Shinjer Li, Saleh Mostafa, Israa Saleh, Raymond Benza, Deepak R. Talreja, Matthew R. Summers   +7 more
wiley   +1 more source

Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system

, 2007
Percutaneous valve replacement for severe aortic stenosis has shown to be an alternative treatment option for non-surgical candidates. We report on the first successful valve in valve procedure in an 80-year-old patient with a severe regurgitation of a ...
Buellesfeld, Lutz, Grube, Eberhard, Wenaweser, Peter, Gerckens, Ulrich, Wenaweser, Peter Martin   +4 more
core   +1 more source

Challenging Anticoagulation With Warfarin and Heparin Following Mechanical Mitral Valve Replacement in a Patient With Infective Endocarditis: A Case Report Highlighting Diagnostic Difficulties

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Warfarin remains the cornerstone of anticoagulation therapy following mechanical heart valve replacement. However, challenging anticoagulation responses, resistance to warfarin, and even more rarely to both warfarin and heparin pose significant clinical challenges and complicate management strategies.
Musawer Khan, Ayesha Ahmad, Moin Khan, F. N. U. Zainullah, Nauman Khan, Fatima Nazir, Wakil Ahmed, Naqeeb Ullah, Muhammad Anees, Kamil Ahmad Kamil   +9 more
wiley   +1 more source

Supra‐Annular Versus Intra‐Annular Devices for Transcatheter Aortic Valve‐in‐Valve Replacement: The PANDORA International Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background As transcatheter aortic valve replacement (TAVR) expands to younger, lower‐risk populations, the need for repeat procedures due to valve degeneration is expected to increase.
Antonio Popolo Rubbio, Antonio Sisinni, Enrico Criscione, Enrico Poletti, Nicolas Van Mieghem, Gaspare S. Cannone, Didier Tchétché, Azeem Latib, Andrea Scotti, Ole De Backer, Michele Morosato, Damiano Regazzoli, Ignacio A. Santos, Michiel Voskuil, Matjaz Bunc, David Hildick‐Smith, Joachim Schofer, Christina Brinkmann, Kush P. Patel, Andreas Baumbach, Francesco Bedogni, Luca Testa   +21 more
doaj   +1 more source

Degeneration of Bioprosthetic Heart Valves: Update 2020

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
The implantation of bioprosthetic heart valves (BHVs) is increasingly becoming the treatment of choice in patients requiring heart valve replacement surgery.
Alexander E. Kostyunin, Arseniy E. Yuzhalin, Maria A. Rezvova, Evgeniy A. Ovcharenko, Tatiana V. Glushkova, Anton G. Kutikhin   +5 more
doaj   +1 more source